Adjuvant Chemotherapy in Patients With Early-Stage Non-Small Cell Lung Cancer. - Suppr | 超能文献

Adjuvant Chemotherapy in Patients With Early-Stage Non-Small Cell Lung Cancer.

作者信息

Inamura Kentaro

机构信息

Division of Pathology, The Cancer Institute, Japanese Foundation for Cancer Research, Tokyo, Japan.

出版信息

JAMA Oncol. 2021 Apr 1;7(4):637-638. doi: 10.1001/jamaoncol.2020.8189.

DOI:10.1001/jamaoncol.2020.8189

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

Adjuvant Chemotherapy in Patients With Early-Stage Non-Small Cell Lung Cancer.

JAMA Oncol. 2021 Apr 1;7(4):637-638. doi: 10.1001/jamaoncol.2020.8189.

2

Adjuvant Chemotherapy in Patients With Early-Stage Non-Small Cell Lung Cancer.早期非小细胞肺癌患者的辅助化疗

JAMA Oncol. 2021 Apr 1;7(4):636-637. doi: 10.1001/jamaoncol.2020.8186.

3

Adjuvant Chemotherapy in Patients With Early-Stage Non-Small Cell Lung Cancer-Reply.早期非小细胞肺癌患者的辅助化疗——回复

JAMA Oncol. 2021 Apr 1;7(4):638. doi: 10.1001/jamaoncol.2020.8194.

4

[Current state of adjuvant treatment to surgery in the initial stages of nonsmall cell lung cancer].

Rev Clin Esp. 2008 Jun;208(6):302-4. doi: 10.1157/13123190.

5

[The role of adjuvant chemotherapy in operable non-small cell lung cancer].[辅助化疗在可切除非小细胞肺癌中的作用]

Zhongguo Fei Ai Za Zhi. 2011 Mar;14(3):281-5. doi: 10.3779/j.issn.1009-3419.2011.03.15.

6

The new era of immune checkpoint inhibition and target therapy in early-stage non-small cell lung cancer. A review of the literature.早期非小细胞肺癌免疫检查点抑制和靶向治疗的新时代。文献综述。

Clin Lung Cancer. 2022 Mar;23(2):108-115. doi: 10.1016/j.cllc.2021.11.003. Epub 2021 Nov 11.

7

Adjuvant chemotherapy in early-stage non-small cell lung cancer.早期非小细胞肺癌的辅助化疗

Semin Oncol. 2005 Jun;32(3):279-83. doi: 10.1053/j.seminoncol.2005.02.018.

8

Can adjuvant chemotherapy improve survival in patients with early-stage, resected non-small-cell lung cancer?辅助化疗能否提高早期可切除非小细胞肺癌患者的生存率？

Nat Clin Pract Oncol. 2005 Nov;2(11):552-3. doi: 10.1038/ncponc0350.

9

Defining outcomes of patients with clinical stage I small cell lung cancer upstaged at surgery.定义临床 I 期小细胞肺癌患者手术分期升级后的结局。

Lung Cancer. 2017 Jan;103:75-81. doi: 10.1016/j.lungcan.2016.11.016. Epub 2016 Nov 28.

10

Postoperative adjuvant therapy for completely resected early-stage non-small cell lung cancer.完全切除的早期非小细胞肺癌的术后辅助治疗。

Int J Clin Oncol. 2005 Jun;10(3):157-64. doi: 10.1007/s10147-005-0493-x.

引用本文的文献

1

Nano-orchestrated magnetotactic-like navigation for electromagnetic theranostics and immune enhancement via photoautotrophic oxygenation, mild hyperthermia, and ferroptosis.通过光合自养氧合、温和热疗和铁死亡实现用于电磁诊疗和免疫增强的纳米编排类趋磁导航。

J Nanobiotechnology. 2025 Jun 13;23(1):442. doi: 10.1186/s12951-025-03488-7.

2

RYR2 mutation in non-small cell lung cancer prolongs survival via down-regulation of DKK1 and up-regulation of GS1-115G20.1: A weighted gene Co-expression network analysis and risk prognostic models.RYR2 突变通过下调 DKK1 和上调 GS1-115G20.1 延长非小细胞肺癌的生存期：一项基于加权基因共表达网络分析和风险预后模型的研究。

IET Syst Biol. 2022 Apr;16(2):43-58. doi: 10.1049/syb2.12038. Epub 2021 Dec 7.